Monitoring neurodegeneration in diabetes using adult neural stem cells derived from the olfactory bulb

Stem Cell Research and Therapy

Volumn 4, Issue 3, 2013, Pages

  Hidaka, Ryo ^a   Machida, Masanao ^a   Fujimaki, Shin ^a   Terashima, Kazuyuki ^a   Asashima, Makoto ^a   Kuwabara, Tomoko ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Diabetes; Hippocampus; Insulin; Neural stem cells; Olfactory bulb

Indexed keywords

GLUTAMATE RECEPTOR; GLUTAMATE TRANSPORTER; INSULIN; VOLTAGE GATED SODIUM CHANNEL; EXCITATORY AMINO ACID TRANSPORTER 3; NERVE CELL ADHESION MOLECULE; SCN1B PROTEIN, RAT; SLC1A1 PROTEIN, RAT; VOLTAGE GATED SODIUM CHANNEL BETA 1 SUBUNIT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; GENE EXPRESSION; HIPPOCAMPUS; IMMUNOPRECIPITATION; MALE; MONITORING; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; OLFACTORY BULB; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA EXTRACTION; STREPTOZOCIN DIABETES; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CENTRAL NERVOUS SYSTEM; CYTOLOGY; DOWN REGULATION; EXPERIMENTAL DIABETES MELLITUS; GENETICS; METABOLISM; PATHOLOGY; UPREGULATION;

RATTUS;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; DIABETES MELLITUS, EXPERIMENTAL; DOWN-REGULATION; EXCITATORY AMINO ACID TRANSPORTER 3; HIPPOCAMPUS; INSULIN; MALE; NEURAL CELL ADHESION MOLECULES; NEURAL STEM CELLS; NEUROGENESIS; OLFACTORY BULB; RATS; RECEPTORS, GLUTAMATE; UP-REGULATION; VOLTAGE-GATED SODIUM CHANNEL BETA-1 SUBUNIT; VOLTAGE-GATED SODIUM CHANNELS;

EID: 84877612659     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt201     Document Type: Article

References (45)

1. IGF-I has a direct proliferative effect in adult hippocampal progenitor cells. Aberg MAI, Aberg ND, Palmer TD, Alborn AM, Carlsson-Skwirut C, Bang P, Rosengren LE, Olsson T, Gage FH, Eriksson PS, Mol Cell Neurosci 2003 24 23 40 10.1016/S1044-7431(03)00082-4 14550766
2. Isolation, characterization, and use of stem-cells from the CNS. Gage FH, Ray J, Fisher LJ, Annu Rev Neurosci 1995 18 159 192 10.1146/annurev.ne.18. 030195.001111 7605059
3. Mammalian neural stem cells. Gage FH, Science 2000 287 1433 1438 10.1126/science.287.5457.1433 10688783
4. Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells. D'Amour KA, Gage FH, Proc Natl Acad Sci USA 2003 100 11866 11872 10.1073/pnas.1834200100 12923297
5. In vivo fate analysis reveals the multipotent and self-renewal capacities of Sox2(+) neural stem cells in the adult hippocampus. Suh H, Consiglio A, Ray J, Sawai T, D'Amour KA, Gage FH, Cell Stem Cell 2007 1 515 528 10.1016/j.stem.2007.09.002 18371391
6. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Pagano SF, Impagnatiello F, Girelli M, Cova L, Grioni E, Onofri M, Cavallaro M, Etteri S, Vitello F, Giombini S, Solero CL, Parati EA, Stem Cells 2000 18 295 300 10.1634/stemcells.18-4-295 10924096
7. Adult human olfactory neural progenitors cultured in defined medium. Zhang XD, Klueber KM, Guo ZF, Lu CL, Roisen FJ, Exp Neurol 2004 186 112 123 10.1016/j.expneurol.2003.10.022 15026250
8. Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Dore S, Kar S, Quirion R, Proc Natl Acad Sci USA 1997 94 4772 4777 10.1073/pnas.94.9.4772 9114067
9. IGF-I and IGF-II protect cultured hippocampal and septal neurons against calcium-mediated hypoglycemic damage. Cheng B, Mattson MP, J Neurosci 1992 12 1558 1566 1313498
10. IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. Hsieh J, Aimone JB, Kaspar BK, Kuwabara T, Nakashima K, Gage FH, J Cell Biol 2004 164 111 122 10.1083/jcb.200308101 14709544
11. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F, Neuron 1995 14 717 730 10.1016/0896-6273(95)90216-3 7718235
12. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Carson MJ, Behringer RR, Brinster RL, McMorris FA, Neuron 1993 10 729 740 10.1016/0896-6273(93)90173-O 8386530
13. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS, J Neurosci 2000 20 2896 2903 10751442
14. Insulin-like growth factor-1 is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2. Arsenijevic Y, Weiss S, Schneider B, Aebischer P, J Neurosci 2001 21 7194 7202 11549730
15. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Ferraro F, Lymperi S, Méndez-Ferrer S, Saez B, Spencer JA, Yeap BY, Masselli E, Graiani G, Prezioso L, Rizzini EL, Mangoni M, Rizzoli V, Sykes SM, Lin CP, Frenette PS, Quaini F, Scadden DT, Sci Transl Med 2011 3 104ra101 http://www.ncbi.nlm.nih.gov/pubmed/?term=Diabetes +impairs+hematopoietic+stem+cell+mobilization+by+altering+niche+function 10.1126/scitranslmed.3002191 21998408
16. Satellite cells derived from streptozotocin-diabetic rats display altered fusion parameters in vitro. Brannon MA, Dodson MV, Wheeler BA, Mathison BD, Mathison BA, Metabolism 1989 38 348 352 10.1016/0026-0495(89)90123-6 2524636
17. Skeletal muscle stem cells: effects of aging and metabolism on muscle regenerative function. Jang YC, Sinha M, Cerletti M, Dall'Osso C, Wagers AJ, Cold Spring Harb Symp Quant Biol 2011 76 101 111 10.1101/sqb.2011.76.010652 21960527
18. Osteoporosis in diabetes mellitus: possible cellular and molecular mechanisms. Wongdee K, Charoenphandhu N, World J Diabetes 2011 2 41 48 10.4239/wjd.v2.i3.41 21537459
19. Impaired neural stem/progenitor cell proliferation in streptozotocin-induced and spontaneous diabetic mice. Guo J, Yu C, Li H, Liu F, Feng R, Wang H, Meng Y, Li Z, Ju G, Wang J, Neurosci Res 2010 68 329 336 10.1016/j.neures.2010.08.012 20832431
20. Neural stem cells in the diabetic brain. Bachor TP, Suburo AM, Stem Cells Int 2012 2012 820790 23213341
21. Diabetes mellitus and the risk of dementia: the Rotterdam study. Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler MMB, Neurology 1999 53 1937 1942 10.1212/WNL.53.9.1937 10599761
22. Predictors of cognitive impairment in type 1 diabetes. Brismar T, Maurex L, Cooray G, Juntti-Berggren L, Lindstrom P, Ekberg K, Adner N, Andersson S, Psychoneuroendocrinology 2007 32 1041 1051 10.1016/j.psyneuen.2007.08.002 17884300
23. Neurodegenerative disorders associated with diabetes mellitus. Ristow M, J Mol Med (Berl) 2004 82 510 529
24. Diabetes impairs hippocampal function through glucocorticoid-mediated effects on new and mature neurons. Stranahan AM, Arumugam TV, Cutler RG, Lee K, Egan JM, Mattson MP, Nat Neurosci 2008 11 309 317 10.1038/nn2055 18278039
25. The effect of streptozotocin-induced diabetes on cell proliferation in the rat dentate gyrus. Jackson-Guilford J, Leander JD, Nisenbaum LK, Neurosci Lett 2000 293 91 94 10.1016/S0304-3940(00)01502-0 11027841
26. Oestradiol restores cell proliferation in dentate gyrus and subventricular zone of streptozotocin-diabetic mice. Saravia F, Revsin Y, Lux-Lantos V, Beauquis J, Homo-Delarche F, De Nicola AF, J Neuroendocrinol 2004 16 704 710 10.1111/j.1365-2826.2004.01223.x 15271063
27. Olfaction under metabolic influences. Palouzier-Paulignan B, Lacroix MC, Aime P, Baly C, Caillol M, Congar P, Julliard AK, Tucker K, Fadool DA, Chem Senses 2012 37 769 797 10.1093/chemse/bjs059 22832483
28. A physiological increase of insulin in the olfactory bulb decreases detection of a learned aversive odor and abolishes food odor-induced sniffing behavior in rats. Aimé P, Hegoburu C, Jaillard T, Degletagne C, Garcia S, Messaoudi B, Thevenet M, Lorsignol A, Duchamp C, Mouly AM, Julliard AK, PLoS One 2012 7 51227 10.1371/journal.pone.0051227 23251461
29. Insulin biosynthesis in neuronal progenitors derived from adult hippocampus and the olfactory bulb. Kuwabara T, Kagalwala MN, Onuma Y, Ito Y, Warashina M, Terashima K, Sanosaka T, Nakashima K, Gage FH, Asashima M, EMBO Mol Med 2011 3 742 754 10.1002/emmm.201100177 21984534
30. Comparative analysis of in vitro conditions for rat adult neural progenitor cells. Dictus C, Tronnier V, Unterberg A, Herold-Mende C, J Neurosci Methods 2007 161 250 258 10.1016/j.jneumeth.2006.11.012 17207861
31. Reduction in paracrine Wnt3 factors during aging causes impaired adult neurogenesis. Okamoto M, Inoue K, Iwamura H, Terashima K, Soya H, Asashima M, Kuwabara T, FASEB J 2011 25 3570 3582 10.1096/fj.11-184697 21746862
32. Wnt-mediated activation of NeuroD1 and retro-elements during adult neurogenesis. Kuwabara T, Hsieh J, Muotri A, Yeo G, Warashina M, Lie DC, Moore L, Nakashima K, Asashima M, Gage FH, Nat Neurosci 2009 12 1097 1105 10.1038/nn.2360 19701198
33. Neurod1 is essential for the survival and maturation of adult-born neurons. Gao ZL, Ure K, Ables JL, Lagace DC, Nave KA, Goebbels S, Eisch AJ, Hsieh J, Nat Neurosci 2009 12 1090 1092 10.1038/nn.2385 19701197
34. Multipotent cell lineages in early mouse development depend on SOX2 function. Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R, Genes Dev 2003 17 126 140 10.1101/gad.224503 12514105
35. Vertebrate neurogenesis is counteracted by Sox1-3 activity. Bylund M, Andersson E, Novitch BG, Muhr J, Nat Neurosci 2003 6 1162 1168 10.1038/nn1131 14517545
36. Sox2 deficiency causes neurodegeneration and impaired neurogenesis in the adult mouse brain. Ferri AL, Cavallaro M, Braida D, Di Cristofano A, Canta A, Vezzani A, Ottolenghi S, Pandolfi PP, Sala M, DeBiasi S, Nicolis SK, Development 2004 131 3805 3819 10.1242/dev.01204 15240551
37. Association study of the human FZD3 locus with schizophrenia. Yang J, Si T, Ling Y, Ruan Y, Han Y, Wang X, Zhang H, Kong Q, Li X, Liu C, Zhang D, Zhou M, Yu Y, Liu S, Shu L, Ma D, Wei J, Zhang D, Biol Psychiatry 2003 54 1298 1301 10.1016/S0006-3223(03)00291-9 14643098
38. Expression of the type I diabetes-associated gene LRP5 in macrophages, vitamin A system cells, and the islets of Langerhans suggests multiple potential roles in diabetes. Figueroa DJ, Hess JF, Ky B, Brown SD, Sandig V, Hermanowski-Vosatka A, Twells RCJ, Todd JA, Austin CP, J Histochem Cytochem 2000 48 1357 1368 10.1177/002215540004801006 10990489
39. Association of C/T polymorphism in the LRP5 gene with circulating follicle stimulating hormone in Caucasian postmenopausal women. Zofkova I, Hill M, Zajickova K, Physiol Res 2007 56 735 739 17087607
40. Cloning and expression of the rat p8 cDNA, a new gene activated in pancreas during the acute phase of pancreatitis, pancreatic development, and regeneration, and which promotes cellular growth. Mallo GV, Fiedler F, Calvo EL, Ortiz EM, Vasseur S, Keim V, Morisset J, Iovanna JL, J Biol Chem 1997 272 32360 32369 10.1074/jbc.272.51.32360 9405444
41. Glucose-dependent expansion of pancreatic beta-cells by the protein p8 in vitro and in vivo. Päth G, Opel A, Gehlen M, Rothhammer V, Niu X, Limbert C, Romfeld L, Hügl S, Knoll A, Brendel MD, Bretzel RG, Seufert J, Am J Physiol Endocrinol Metab 2006 291 1168 E1176 10.1152/ajpendo.00436.2005 16822955
42. Nuclear protein p8 is associated with glucose-induced pancreatic beta-cell growth. Path G, Opel A, Knoll A, Seufert J, Diabetes 2004 53 82 S85 10.2337/diabetes.53.2007.S82 14749270
43. Pancreatic islet-specific overexpression of Reg3beta protein induced the expression of pro-islet genes and protected the mice against streptozotocin-induced diabetes mellitus. Xiong X, Wang X, Li B, Chowdhury S, Lu Y, Srikant CB, Ning G, Liu JL, Am J Physiol Endocrinol Metab 2011 300 669 E680 10.1152/ajpendo.00600.2010 21245462
44. Regenerative medicine using adult neural stem cells: the potential for diabetes therapy and other pharmaceutical applications. Kuwabara T, Asashima M, J Mol Cell Biol 2012 4 133 139 10.1093/jmcb/mjs016 22577214
45. The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention. Sheldon AL, Robinson MB, Neurochem Int 2007 51 333 355 10.1016/j.neuint.2007.03.012 17517448